Right, so if your referring to delivering on deadlines then no i don't think PAR will be able to deliver on the given deadlines for P3 OA. This is partly since we are unsure when 1) the P3 can begin and 2) the funding situation. In saying that, I don't consider the absence of MPS results to be a missed deadline since it is not a CRO conducting the MPS trial which will be the case with the P3 OA trial.
PAR. SP, page-656
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.010(5.13%) |
Mkt cap ! $70.04M | |||
| Open | High | Low | Value | Volume |
| 20.5¢ | 21.0¢ | 20.0¢ | $207.2K | 1.015M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 19006 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 57971 | 5 |
View Market Depth
| Last trade - 15.45pm 10/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |